Evidence map›Paper›PMID 36508673›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Selective involvement of UGGT variant: UGGT2 in protecting mouse embryonic fibroblasts from saturated lipid-induced ER stress.

Hui-Hsing Hung, Yasuko Nagatsuka, Tatiana Soldà, Vamsi K Kodali, Kazuhisa Iwabuchi, Hiroyuki Kamiguchi, Koki Kano, Ichiro Matsuo, Kazutaka Ikeda, Randal J Kaufman and 3 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Hui-Hsing HungRIKEN Center for Brain Science, Wako, Saitama 351-0198, Japan.ORCID 0000-0003-1498-180X
Yasuko NagatsukaRIKEN Center for Brain Science, Wako, Saitama 351-0198, Japan.
Tatiana SoldàFaculty of Biomedical Sciences, Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland.
Vamsi K KodaliDegenerative Diseases Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037.ORCID 0000-0001-8941-9761
Kazuhisa IwabuchiInstitute for Environmental and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, Chiba 279-0021, Japan.ORCID 0000-0002-4805-4206
Hiroyuki KamiguchiRIKEN Center for Brain Science, Wako, Saitama 351-0198, Japan.
Koki KanoDivision of Molecular Science, Gunma University, Maebashi 371-8510, Japan.ORCID 0000-0001-5724-9905
Ichiro MatsuoDivision of Molecular Science, Gunma University, Maebashi 371-8510, Japan.ORCID 0000-0003-0740-1184
Kazutaka IkedaLaboratory of Biomolecule Analysis, Kazusa DNA Research Institute, Chiba 292-0818, Japan.
Randal J KaufmanDegenerative Diseases Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037.ORCID 0000-0003-4277-316X
Maurizio MolinariFaculty of Biomedical Sciences, Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland.
Peter GreimelRIKEN Center for Brain Science, Wako, Saitama 351-0198, Japan.ORCID 0000-0002-4931-6183
Yoshio HirabayashiInstitute for Environmental and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, Chiba 279-0021, Japan.
RIKEN Center for Brain Science · JPGunma University · JPJuntendo University · JPSanford Burnham Prebys Medical Discovery Institute · USÉcole Polytechnique Fédérale de Lausanne · CHKazusa DNA Research Institute · JPUniversità della Svizzera italiana · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Secretory proteins and lipids are biosynthesized in the endoplasmic reticulum (ER). The "protein quality control" system (PQC) monitors glycoprotein folding and supports the elimination of terminally misfolded polypeptides. A key component of the PQC system is Uridine diphosphate glucose:glycoprotein glucosyltransferase 1 (UGGT1). UGGT1 re-glucosylates unfolded glycoproteins, to enable the re-entry in the protein-folding cycle and impede the aggregation of misfolded glycoproteins. In contrast, a complementary "lipid quality control" (LQC) system that maintains lipid homeostasis remains elusive. Here, we demonstrate that cytotoxic phosphatidic acid derivatives with saturated fatty acyl chains are one of the physiological substrates of UGGT2, an isoform of UGGT1. UGGT2 produces lipid raft-resident phosphatidylglucoside regulating autophagy. Under the disruption of lipid metabolism and hypoxic conditions, UGGT2 inhibits PERK-ATF4-CHOP-mediated apoptosis in mouse embryonic fibroblasts. Moreover, the susceptibility of UGGT2 KO mice to high-fat diet-induced obesity is elevated. We propose that UGGT2 is an ER-localized LQC component that mitigates saturated lipid-associated ER stress via lipid glucosylation.

Indexed as

FibroblastsGlucosyltransferasesAnimalsEndoplasmic Reticulum StressGlycoproteinsLipidsMiceGlucosyltransferasesGlycoproteinsLipidsCHOPhypoxiaphosphatidylglucosidesaturated lipidUGGT

Identifiers

PMID36508673
PMCPMC9907099
OpenAlexW4311501755

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.